Reactome | GSK1059615 [cytosol]

Schema > ChemicalDrug > Entries

candidateOf	[CandidateSet:R-ALL-2399811] PI3K/mutant PI3K inhibitors [cytosol]
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:2399727] Orlic-Milacic, M, 2012-07-12
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992 [DatabaseIdentifier:9628004] ChEBI:71955
dbId	2399768
disease	[Disease:1500689] cancer
displayName	GSK1059615 [cytosol]
inDisease	true
literatureReference	[LiteratureReference:2399870] Targeting the phosphoinositide 3-kinase pathway in cancer
maxDepth	1
modified	[InstanceEdit:9645637] Orlic-Milacic, Marija, 2019-05-15
name	GSK1059615
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:9826] GSK1059615 [Guide to Pharmacology:9826]
schemaClass	ChemicalDrug
stId	R-ALL-2399768
updateTrackers	[UpdateTracker:9900840] Update Tracker - [ChemicalDrug:2399768] GSK1059615 [cytosol] - v70:[add_removeReferenceEntity]

(updatedInstance)	[UpdateTracker:9900840] Update Tracker - [ChemicalDrug:2399768] GSK1059615 [cytosol] - v70:[add_removeReferenceEntity]
(hasCandidate)	[CandidateSet:R-ALL-2399811] PI3K/mutant PI3K inhibitors [cytosol]

Cite Us!